As filed with the Securities and Exchange Commission on February 11, 2004
Registration No. 333-____
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
CHORDIANT SOFTWARE, INC.
(Exact name of Registrant as specified in its charter)
Delaware |
93-1051328 |
(State of incorporation) |
(I.R.S. Employer Identification No.) |
20400 Stevens Creek Boulevard, Suite #400
Cupertino, California 95014
(408) 517-6100
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Stephen Kelly
Chief Executive Officer
Chordiant Software, Inc.
20400 Stevens Creek Blvd., Suite #400
Cupertino, CA 95014
(408) 517-6100
(Name, address, including zip code, and telephone number, including
area code, of agent for service)
Copy
to:
Nancy H. Wojtas, Esq.
Cooley Godward LLP
Five Palo Alto Square
3000 El Camino Real
Palo Alto, California 94306
(650) 843-5000
Approximate date of commencement of proposed sale to the public: From time to time after this Registration Statement becomes effective as determined by market conditions and other factors.
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. o
If any of the securities being offered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. [x]
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of earlier effective registration statement for the same offering. o
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. oIf delivery of the prospectus is expected to be made pursuant to Rule 434 please check the following box. o
CALCULATION OF REGISTRATION FEE
Title of Securities to be Registered |
Amount to be Registered |
Proposed Maximum Offering Price per Share (1),(2) |
Proposed Maximum Aggregate Offering Price (2) |
Amount of Registration Fee |
Common Stock, $0.001 par value per share |
4,854,368 |
$5.32 | $25,825,237.76 | $3,272.06 |
(1) Pursuant to Rule 416 of the Securities Act, this Registration Statement
also covers such indeterminable additional shares as may become issuable as a
result of any future stock splits, stock dividends or similar transactions.
(2) Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(c) under the Securities Act on the basis of the high and
low prices of our common stock on February 5, 2004, as quoted on the Nasdaq
National Market.
The registrant hereby amends this Registration Statement on such date or dates
as may be necessary to delay its effective date until the registrant shall file
a further amendment which specifically states that this Registration Statement
shall thereafter become effective in accordance with Section 8(a) of the
Securities Act or until this Registration Statement shall become effective on
such date as the Commission, acting pursuant to said Section 8(a), may
determine.
Subject to completion, dated February 11, 2004
The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in ay state where the offer or sale is not permitted.
PROSPECTUS
CHORDIANT SOFTWARE, INC.
4,854,368 Shares of Common Stock
We are registering our common stock for resale by the selling stockholder
identified in this prospectus. We will not receive any of the proceeds from the
sale of shares by the selling stockholder. The selling stockholder may sell its
shares of our common stock in one or more transactions at fixed prices, at
prevailing market prices at the time of sale, at prices related to the
prevailing market prices, at varying prices determined at the time of sale, or
at negotiated prices.
Our common stock is traded on the Nasdaq National Market under the symbol "CHRD."
The closing sale price on February 10, 2004, as reflected on the Nasdaq National
Market, was $5.55 per share.
Investing in our common stock involves a high degree of risk. See the section
entitled "Risk Factors" commencing on page 2.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.
The date of this prospectus is _______, 2004
TABLE OF CONTENTS
You should rely only on the information or representation provided in this
prospectus or incorporated by reference into this prospectus. We have not
authorized anyone to provide you with any different information or to make any
different representations in connection with any offering made by this
prospectus. This prospectus does not constitute an offer to sell, or a
solicitation of an offer to buy, in any state where the offer or sale is
prohibited. Neither the delivery of this prospectus, nor any sale made under
this prospectus, shall, under any circumstances, imply that the information in
this prospectus is correct as of any date after the date of this prospectus.
Chordiant and the Chordiant logo are registered trademarks of Chordiant
Software, Inc. This prospectus also includes trademarks owned by other parties.
All other trademarks mentioned property of their respective owners.
This summary does not contain all the information you should consider
before buying shares in the offer. The following summary is qualified in its
entirety by the more detailed information, including "Risk Factors," appearing
elsewhere in this prospectus or incorporated by reference in this prospectus.
The entire prospectus, including the documents incorporated by reference in this
prospectus, should be read carefully.
Chordiant Software, Inc.
Chordiant Software, Inc. is an enterprise software vendor that offers
transactional customer software solutions for global companies that seek to
improve the quality of customer interactions and to reduce costs through
increased employee productivity and process efficiencies. Chordiant concentrates
on serving global customers in retail financial services, communications and
consumer direct industries.
We deliver a complete customer system that includes software applications and
tools and services that enable businesses to successfully integrate their
customer information and corporate systems for an accurate, real-time view of
their customers across multiple forms of customer interaction.
We believe our system offers great flexibility to businesses to set business
policies and processes to control the quality of servicing, fulfillment and
marketing to their customers. Our system enables companies to control and change
their business policies and process. We believe that we are leaders in providing
business process driven solutions for customer management.
Our software architecture is based on the J2EE (Java 2 Enterprise Edition)
industry standard that we believe is widely supported by vendors and widely
adopted by business customers in the industries we serve. We believe that
solutions based on other architectures are less capable of meeting the current
and future requirements of global companies.
Our principal executive offices are located at 20400 Stevens Creek Blvd., Suite
#400, Cupertino, CA 95014, and our telephone number is (408) 517-6100. Our
Internet address is www.chordiant.com. The information on our web site is not
incorporated by reference into this prospectus and does not constitute a part of
this prospectus.
Recent Unaudited Financial Information
Total revenues for the quarter ended December 31, 2003 were $19.6 million,
compared to $17.8 million for the quarter ended September 30, 2003 and $17.1
million for the quarter ended December 31, 2002. For the quarter ended December
31, 2003, we had a net loss of $3.9 million, or $0.06 per share, compared to a
net loss of $8.6 million, or $0.15 per share, for the quarter ended December 31,
2002.
1
An investment in our shares involves a high degree of risk. We operate in a
dynamic and rapidly changing environment that involves numerous risks and
uncertainties. You should not make an investment in these shares if you cannot
afford to lose your entire investment. Before purchasing these shares, you
should carefully consider the following risk factors, as well as other
information contained in this prospectus or incorporated by reference into this
prospectus, in evaluating an investment in the shares of common stock offered by
this prospectus. If any of the events or circumstances described in the
following risks factors actually occurs, our business, financial condition, or
results of operations could be materially adversely affected and the trading
price of our common stock could decline.
Weakness in technology spending in our target markets combined with
geopolitical concerns and vendor viability concerns could make the closing of
license transactions to new and existing customers difficult.
Our revenues fell in the nine months ended September 30, 2003 compared to
revenues for the nine months ended September 30, 2002. Our revenues will
continue to decrease in 2004 if we are unable to enter into new large-scale
license transactions with new and existing customers. The current state of world
affairs and geopolitical concerns have left many customers reluctant to enter
into new large value license transactions without some assurance that the
vendors will continue to operate and that the economy both in the customer's
home country and worldwide will have some economic and political stability. The
issues of vendor viability including our limited resources and geopolitical
instability will continue to make closing large license transactions difficult.
Our ability to enter into new large license transactions also directly affects
our ability to create additional consulting services and maintenance revenues,
on which we also depend.
We expect to continue to incur losses on a generally accepted accounting
basis and may not achieve or maintain profitability, which would cause our stock
price to decline.
We incurred losses of $2.1 million and $12.5 million for the three and nine
months ended September 30, 2003, respectively. As of September 30, 2003, we had
an accumulated deficit of $185.0 million. We may continue to incur losses during
the first half of 2004 and cannot be certain that we can achieve or generate
sufficient revenues to achieve profitability. Cash and cash equivalents,
short-term investments and restricted cash and long-term restricted cash at
September 30, 2003 and December 31, 2002 was $34.2 million and $41.5 million,
respectively.
Because a small number of customers account for a substantial portion of our
revenues, our revenues are dependent upon our ability to continue to win large
contracts with new and existing customers.
We derive a significant portion of our software license revenues in each quarter
from a limited number of customers. The loss of a major customer in a particular
quarter could cause a decrease in revenues and net income. For the three months
ended September 30, 2003, Royal Bank of Scotland and Canadian Imperial Bank of
Commerce accounted for approximately 22% and 11% of our total revenues,
respectively. For the three months ended September 30, 2002, USAA accounted for
approximately 43% of our total revenues, respectively. For the nine months ended
September 30, 2003, Barclays and Royal Bank of Scotland accounted for
approximately 10% and 14% of our total revenues, respectively. For the nine
months ended September 30, 2002, USAA, Hutchinson 3 G and Lloyds TBS accounted
for approximately 21%, 15% and 12% of our total revenues, respectively. While
our customer concentration has fluctuated, we expect that a limited number of
customers will continue to account for a substantial portion of our revenues. As
a result, if we lose a major customer, or if a contract is delayed or cancelled
or we do not contract with new major customers, our revenues and net loss would
be adversely affected. In addition, customers that have accounted for
significant revenues in the past may not generate revenues in any future period,
causing our failure to obtain new significant customers or additional orders
from existing customers to materially affect our operating results.
If we fail to adequately address the risks associated with our international
operations, our operating expenses and net income will be adversely affected.
2
Table of contents
For the three months ended September 30, 2003, international revenues were $12.7
million or approximately 71% of our total revenues. For the three months ended
September 30, 2002, international revenues were $9.0 million or approximately
48% of our total revenues. For the nine months ended September 30, 2003,
international revenues were $38.5 million or approximately 79% of our total
revenues. For the nine months ended September 30, 2002, international revenues
were $39.7 million or approximately 70% of our total revenues.. While we expect
North American revenues to increase as a percentage of our overall revenues,
international revenues will continue to represent a significant portion of our
total revenues in future periods. We have faced, and will continue to face,
risks associated with:
w Difficulties in managing our widespread operations;
w Difficulties in hiring qualified local personnel;
w Seasonal fluctuations in customer orders;
w Longer accounts receivable collection cycles;
w Expenses associated with licensing products and servicing customers in foreign
markets;
w Currency fluctuation and hedging activities; and
w Economic downturns in international economies.
Any of these factors could have a significant impact on our ability to license
products on a competitive and timely basis and could adversely affect our
operating expenses and net income. Our international sales are denominated in
both the U.S. dollar and in local currencies. As a result, increases in the
value of the U.S. dollar relative to foreign currencies could make our products
less competitive in international markets and could negatively affect our
operating results and cash flows
Competition in our markets is intense and could reduce our sales and prevent
us from achieving profitability.
Increased competition in our markets could result in price reductions for our
products and services, reduced gross margins and loss of market share, any one
of which could reduce our future revenues. The market for our products is
intensely competitive, evolving and subject to rapid technological change. We
consider our primary competition to be from internal development, custom systems
integration projects and application software competitors. In particular, we
compete with:
w Internal information technology departments: in-house information technology
departments of potential customers have developed or may develop systems that
provide some or all of the functionality of our products. We expect that
internally developed application integration and process automation efforts will
continue to be a significant source of competition.
w Point application vendors: we compete with providers of stand-alone point
solutions for web-based customer relationship management and traditional
client/server-based, call-center service customer and sales-force automation
solution providers.
Many of our competitors have greater resources and broader customer
relationships than we do. In addition, many of these competitors have extensive
knowledge of our industry. Current and potential competitors have established,
or may establish, cooperative relationships among themselves or with third
parties to offer a single solution and to increase the ability of their products
to address customer needs.
We may experience a shortfall in revenue, earnings, cash flow or otherwise
fail to meet public market expectations, which could materially and adversely
affect our business, the market price of our common stock and our liquidity.
3
Our revenues and operating results may fluctuate significantly because of a
number of factors, many of which are outside of our control. Some of these
factors include:
w Size and timing of individual license transactions;
w Delay or deferral of customer implementations of our products;
w Lengthening of our sales cycle;
w Further deterioration and changes in domestic and foreign markets and
economies;
w Success in expanding our global services organization, direct sales force and
indirect distribution channels;
w Timing of new product introductions and product enhancements;
w Appropriate mix of products licensed and services sold;
w Levels of international transactions;
w Activities of and acquisitions by competitors;
w Product and price competition; and
w Our ability to develop and market new products and control costs.
One or more of the foregoing factors may cause our operating expenses to be
disproportionately high during any given period or may cause our revenues and
operating results to fluctuate significantly. Based upon the preceding factors,
we may experience a shortfall in revenues, earnings or liquidity or otherwise
fail to meet public market expectations, which could materially and adversely
affect our business, financial condition, results of operations and the market
price of our common stock.
Our operating results fluctuate significantly and delays in implementation of
our products may cause unanticipated declines in revenues or cash flow, which
could disappoint investors and result in a decline in our stock price.
Our quarterly revenues depend primarily upon product implementation by our
customers. We have historically recognized most of our license and services
revenue through the percentage-of-completion method, using labor hours incurred
as the measure of progress towards completion of implementation of our products,
and we expect this practice to continue. Thus, delays in implementation by our
customers and systems integration partners would reduce our quarterly revenue.
Historically, a significant portion of new customer orders have been booked in
the third month of the calendar quarter, with many of these bookings occurring
in the last two weeks of the third month. We expect this trend to continue and,
therefore, any failure or delay in bookings would decrease our quarterly
deferred revenue. If our revenues or operating margins are below the
expectations of the investment community, our stock price is likely to decline.
If we fail to maintain and expand our relationships with systems integrators
and other business partners, our ability to develop, market, sell, and support
our products may be adversely affected.
Our development, marketing and distribution strategies increasingly rely on our
ability to form long-term strategic relationships with system integrators and
business alliances and in particular, with IBM and Accenture. These business
relationships often consist of joint marketing programs, technology partnerships
and resale and distribution arrangements. Although most aspects of these
relationships are contractual in nature, many important aspects of these
relationships depend on the continued cooperation between the parties.
Divergence in strategy, change in focus, competitive product offerings or
potential contract defaults may interfere with our ability to develop, market,
sell, or support our products, which in turn could harm our business. If either
IBM or Accenture were to terminate their agreements with us or our relationship
were to deteriorate, it could have a material adverse effect on our business,
financial condition and results of operations. In many cases, these parties have
extensive relationships with our existing and potential customers and influence
the decisions of these customers. A number of our competitors have stronger
relationships with IBM and Accenture and, as a result, these parties may be more
likely to recommend competitors' products and services.
4
Table of contents
Failure to successfully customize or implement our products for a customer
could prevent recognition of revenues, collection of amounts due or cause legal
claims by the customer.
If a customer is not able to customize or deploy our products successfully, the
customer may not complete expected product deployment, which could prevent or
delay recognition of revenues and collection of amounts due, and could result in
claims against us. We have, in the past, had disputes with customers concerning
product performance.
Our primary products have a long sales and implementation cycle, which makes
it difficult to predict our quarterly results and may cause our operating
results to vary significantly.
The period between initial contact with a prospective customer and the
implementation of our products is unpredictable and often lengthy, ranging to
date from three to twenty-four months. Thus, revenue and cash receipt could vary
significantly from quarter to quarter. Any delays in the implementation of our
products could cause reductions in our revenues. The licensing of our products
is often an enterprise-wide decision that generally requires us to provide a
significant level of education to prospective customers about the use and
benefits of our products. The implementation of our products involves
significant commitment of technical and financial resources and is commonly
associated with substantial implementation efforts that may be performed by us,
by the customer or by third-party systems integrators. Customers generally
consider a wide range of issues before committing to purchase our products,
including product benefits, ability to operate with existing and future computer
systems, vendor financial stability and longevity, ability to accommodate
increased transaction volume and product reliability.
If we are not able to successfully manage our partner operations in India,
our operations and financial results may be adversely affected.
In fiscal 2003 we entered into an agreement with an independent contracting
company with global technical resources and an operations center in Bangalore,
India. The agreement provides for the independent contractor, at our direction,
to attract, train, assimilate and retain sufficient highly qualified personnel
to perform technical support and certain sustaining engineering functions. In
fiscal 2004 we plan to significantly increase the size of this organization and
expand its scope. The expansion of this organization is an important component
of our strategy to address the business needs of our customers and manage our
expenses. The success of this operation will depend on our ability and our
independent contractor's ability to attract, train, assimilate and retain highly
qualified personnel in the required periods. A disruption of our relationship
with the independent contractor could adversely affect our operations and
financial results. Failure to effectively manage the organization and operations
will harm our business and financial results.
Our stock price is subject to significant fluctuations.
Since our initial public offering in February 2000, the price of our common
stock has fluctuated widely. We believe that factors such as the risks described
herein or other factors could cause the price of our common stock to continue to
fluctuate, perhaps substantially. In addition, recently, the stock market in
general, and the market for high technology stocks in particular, has
experienced extreme price fluctuations, which have often been unrelated to the
operating performance of the affected companies. Such fluctuations could
adversely affect the market price of our common stock.
We may incur in future periods significant stock-based compensation charges
related to certain stock options and stock awards.
Based on certain accounting standards involving stock compensation, we will
incur variable accounting costs related to the issuance of restricted stock and
stock options, including those associated with our stock option
cancellation/re-grant program. Accounting standards require us to remeasure
compensation cost for such options each reporting period based on changes in the
market value of the underlying common stock. Depending upon movements in the
market value of our common stock, the variable accounting treatment of those
stock options may result in significant additional non-cash compensation costs
in future periods. Refer to the discussions under the caption "Non-Cash
Compensation Expenses" set forth in Management's Discussion and Analysis of
Financial Condition and Results of Operations in our quarterly report on Form
10-Q for the quarter ended September 30, 2003.
5
Table of contents
We are the target of a securities class action complaint and are at risk of
securities class action litigation, which may result in substantial costs and
divert management attention and resources.
Beginning in July 2001, Chordiant and certain of our officers and directors were
named as defendants in several class action shareholder complaints filed in the
United States District Court for the Southern District of New York, now
consolidated under the caption, In re Chordiant Software, Inc. Initial Public
Offering Securities Litigation, Case No. 01-CV-6222. In the amended complaint,
the plaintiffs allege that Chordiant, certain of our officers and directors and
the underwriters of our initial public offering ("IPO") violated the federal
securities laws because the Company's IPO registration statement and prospectus
contained untrue statements of material fact or omitted to state material facts
regarding the compensation to be received by, and the stock allocation practices
of, the IPO underwriters. The plaintiffs seek unspecified monetary damages and
other relief. Similar complaints were filed in the same court against hundreds
of other public companies that conducted IPOs of their common stock in the late
1990s. Although Chordiant and almost all of the other issuers have approved in
principle a tentative settlement with the plaintiffs, it remains subject to a
number of procedural conditions, as well as formal approval by the Court. This
action may divert the efforts and attention of our management and, if determined
adversely to us, could have a material impact on our business.
If our products do not operate effectively in a company-wide environment, we
may lose sales and suffer decreased revenues.
If existing customers have difficulty deploying our products or choose not to
fully deploy our products, it could damage our reputation and reduce revenues.
Our success requires that our products be highly scalable, and able to
accommodate substantial increases in the number of users. Our products are
expected to be deployed on a variety of computer hardware platforms and to be
used in connection with a number of third-party software applications by
personnel who may not have previously used application software systems or our
products. These deployments present very significant technical challenges, which
are difficult or impossible to predict. If these deployments do not succeed, we
may lose future sales opportunities and suffer decreased revenues.
Defects in our products could diminish demand for our products and result in
decreased revenues, decreased market acceptance and injury to our reputation.
Errors may be found from time to time in our new, acquired or enhanced products.
Any significant software errors in our products may result in decreased
revenues, decreased sales, injury to our reputation and/or increased warranty
and repair costs. Although we conduct extensive product testing during product
development, we have in the past discovered software errors in our products as
well as in third party products, and as a result have experienced delays in the
shipment of our new products. The latest major release of our primary product
suite was introduced in December 2003.
To date, our sales have been concentrated in the financial services, travel
and leisure and telecommunications markets, and if we are unable to continue
sales in these markets or successfully penetrate new markets, our revenues may
decline.
Sales of our products and services in three large markets--financial and
insurance services, travel and leisure and telecommunications--accounted for
approximately 79% and 85% of our total revenues for the three months ended
September 30, 2003 and 2002, respectively. Sales of our products and services in
three large markets-financial and insurance services, travel and leisure and
telecommunications-accounted for approximately 81% of our total revenues for
both the nine months ended September 30, 2003 and 2002, respectively. We expect
that revenues from these three markets will continue to account for a
substantial portion of our total revenues in 2004. If we are unable to
successfully increase penetration of our existing markets or achieve sales in
additional markets, or if the overall economic climate of our target markets
deteriorates, our revenues may decline.
In addition, we cannot predict what effect the U.S. presence overseas or
potential or actual political or military conflict have had or are continuing to
have on our existing and prospective customers' decision-making process with
respect to licensing or implementing enterprise-level products such as ours. If
these or other outside factors cause existing or prospective customers to cancel
or delay deployment of products such as ours, our operating results would be
adversely affected.
6
Table of contents
Low gross margin in services revenues could adversely impact our overall
gross margin and income.
Our services revenues have had lower gross margins than our license revenues. As
a result, an increase in the percentage of total revenues represented by
services revenues, or an unexpected decrease in license revenues, could have a
detrimental impact on our overall gross margins. To increase services revenues,
we must expand our services organization, successfully recruit and train a
sufficient number of qualified services personnel and obtain renewals of current
maintenance contracts by our customers. This expansion could further reduce
gross margins in our services revenues.
Because we have reduced the size of our workforce, we may not have the
workforce necessary to support our platform of products, and if we need to
rebuild our workforce in the future, we may not be able to recruit personnel in
a timely manner, which could impact the development and sales of our products.
In 2002 and 2003, we reduced the size of our workforce and may carry out further
reductions in the future. Our recent reductions were intended to align our
operating expenses with our revenue expectations. In the event that demand for
our products increases as a result of a positive turn in the economy, we may
need to rebuild our workforce or increase outsourced functions to companies
based in foreign jurisdictions and we may be unable to hire, train or retain
qualified personnel in a timely manner, which may weaken our ability to market
our products in a timely manner, negatively impacting our operations. Our
success depends largely on ensuring that we have adequate personnel to support
our platform as well as the continued contributions of our key management,
engineering, sales and marketing and professional services personnel.
If we fail to introduce new versions and releases of functional and scalable
products in a timely manner, customers may license competing products and our
revenues may decline.
If we are unable to ship or implement enhancements to our products when planned,
or fail to achieve timely market acceptance of these enhancements, we may suffer
lost sales and could fail to achieve anticipated revenues. We have in the past,
and expect in the future, to derive a majority of our total revenues from the
license of our primary product suite. Our future operating results will depend
on the demand for the product suite by future customers, including new and
enhanced releases that are subsequently introduced. If our competitors release
new products that are superior to our products in performance or price, or if we
fail to enhance our products or introduce new features and functionality in a
timely manner, demand for our products may decline. We have in the past
experienced delays in the planned release dates of new versions of our software
products and upgrades. New versions of our products may not be released on
schedule or may contain defects when released.
We depend on technology licensed to us by third parties, and the loss or
inability to maintain these licenses could prevent or delay sales of our
products.
We license from several software providers technologies that are incorporated
into our products. We anticipate that we will continue to license technology
from third parties in the future. This software may not continue to be available
on commercially reasonable terms, if at all. The loss of the technology licenses
could result in delays in the license of our products until equivalent
technology is developed or identified, licensed and integrated into our
products. Even if substitute technologies are available, there can be no
guarantee that we will be able to license these technologies on commercially
reasonable terms, if at all.
Defects in third party products associated with our products could impair our
products' functionality and injure our reputation.
The effective implementation of our products depends upon the successful
operation of third-party products in conjunction with our products. Any
undetected errors in these third-party products could prevent the implementation
or impair the functionality of our products, delay new product introductions or
injure our reputation. In the past, while our business has not been materially
harmed, product releases have been delayed as a result of errors in third-party
software and we have incurred significant expenses fixing and investigating the
cause of these errors.
7
Table of contents
Our customers and system integration partners may have the ability to alter
our source code and resulting inappropriate alterations could adversely affect
the performance of our products, cause injury to our reputation and increase
operating expenses.
Customers and system integration partners may have access to the computer source
code for certain elements of our products and may alter the source code.
Alteration of our source code may lead to implementation, operation, technical
support and upgrade problems for our customers. This could adversely affect the
market acceptance of our products, and any necessary investigative work and
repairs could cause us to incur significant expenses and delays in
implementation.
If our products do not operate with the hardware and software platforms used
by our customers, our customers may license competing products and our revenues
will decline.
If our products fail to satisfy advancing technological requirements of our
customers and potential customers, the market acceptance of these products could
be reduced. We currently serve a customer base with a wide variety of constantly
changing hardware, software applications and networking platforms. Customer
acceptance of our products depends on many factors such as:
w Our ability to integrate our products with multiple platforms and existing or
legacy systems;
w Our ability to anticipate and support new standards, especially Internet and
enterprise Java standards; and
w The integration of additional software modules and third party software
applications with our existing products.
Our failure to successfully integrate with future acquired or merged
companies and technologies could prevent us from operating efficiently.
Our business strategy includes pursuing opportunities to grow our business, both
through internal growth and through merger, acquisition and technology and other
asset transactions. To implement this strategy, we may be involved in merger and
acquisition activity, additional technology and asset purchase transactions.
Merger and acquisition transactions are motivated by many factors, including,
among others, our desire to grow our business, acquire skilled personnel, obtain
new technologies and expand and enhance our product offerings. Growth through
mergers and acquisitions has several identifiable risks, including difficulties
associated with successfully integrating distinct businesses into new
organizations, the substantial management time devoted to integrating personnel,
technology and entire companies, the possibility that we might not be successful
in retaining the employees, undisclosed liabilities, the failure to realize
anticipated benefits (such as cost savings and synergies) and issues related to
integrating acquired technology, merged/acquired companies or content into our
products (such as unanticipated expenses). Realization of any of these risks in
connection with any technology transaction or asset purchase we have entered
into, or may enter into, could have a material adverse effect on our business,
operating results and financial condition.
If we become subject to intellectual property infringement claims, these
claims could be costly and time-consuming to defend, divert management's
attention, cause product delays and have an adverse effect on our revenues and
net income.
We expect that software product developers and providers of software in markets
similar to our target markets will increasingly be subject to infringement
claims as the number of products and competitors in our industry grows and the
functionality of products overlap. Any claims, with or without merit, could be
costly and time-consuming to defend, divert our management's attention or cause
product delays. If any of our products were found to infringe a third party's
proprietary rights, we could be required to enter into royalty or licensing
agreements to be able to sell our products. Royalty and licensing agreements, if
required, may not be available on terms acceptable to us or at all.
8
DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus, including documents incorporated by reference, contains
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended (the "Exchange Act") and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") that involve risks and
uncertainties. Our actual results could differ materially from those anticipated
in these forward-looking statements as a result of certain factors, including
those set forth under "Risk Factors" and elsewhere in this prospectus
These forward-looking statements relate to future events or our future financial
performance or our expectations, beliefs, plans, and objectives, and are not
historical facts and may be forward-looking. In some cases, you can identify
forward-looking statements by terminology such as "anticipates," "believes,"
"continue," "could," "estimates," "expects," "intends," "may," "plans,"
"potential," "predicts," "should," or "will," or the negative of such terms, or
other comparable terminology. These statements are only predictions and involve
known and unknown risks, uncertainties and other factors, including the risks
outlined under the section entitled "Risk Factors" that may cause our or our
industry's actual results, levels of activity, performance or achievements to be
materially different from any future results, levels or activity, performance or
achievements expressed or implied by such forward-looking statements.
Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee future results, levels of
activity, performance or achievements. Moreover, neither we nor any other person
assumes responsibility for the accuracy and completeness of such statements. We
are under no duty to update any of the forward-looking statements after the date
of this prospectus to conform such statements to actual results, unless required
by law.
9
The proceeds from the sale of the common stock offered pursuant to this prospectus are solely for the account of the selling stockholder. Accordingly, we will not receive any proceeds from the sale of the shares by the selling stockholder.
The selling stockholder owns all of the common shares registered
for sale pursuant to this prospectus. All of the shares offered by the selling
stockholder were acquired pursuant to a purchase agreement providing for our
private sale of the shares to the selling stockholder. We filed a registration
statement (of which this prospectus is a part) for the resale of the shares held
by the selling stockholder in accordance with a registration rights agreement we
entered into with the selling stockholder.
The following table sets forth certain information regarding the selling
stockholder's beneficial ownership of the common stock, as of January 21, 2004
and the selling stockholder's common stock ownership after completion of this
offering. Although we have assumed for purposes of the table below that the
selling stockholder will sell all of the shares offered by this prospectus,
because the selling stockholder may offer from time to time all or some of their
shares covered under this prospectus, or in another permitted manner, no
assurances can be given as to the actual number of shares that will be resold by
the selling stockholder or that will be held by the selling stockholder after
completion of the resales. In addition, the selling stockholder may have sold,
transferred or otherwise disposed of, or may sell, transfer or otherwise dispose
of, at any time or from time to time since the date on which it provided the
information regarding the shares of common stock beneficially owned by it, all
or a portion of the shares of common stock beneficially owned by it in
transactions exempt from the registration requirements of the Securities Act.
The information in the table below is based upon information provided by the
selling stockholder and a Schedule 13G filed by the selling stockholder.
Beneficial ownership is determined in accordance with Rule 13d-3(d) promulgated
by the SEC under the Securities Exchange Act of 1934. Percentage ownership is
based on an aggregate of 69,725,286 shares of our common stock outstanding as of
January 21, 2004.
Name of Selling Stockholder |
Shares Beneficially |
Shares Offered by this |
Shares Beneficially Owned |
|||
|
Shares |
Percent |
|
Shares |
Percent |
|
Acqua Wellington Opportunity I Limited |
4,854,368 |
7.0% |
4,854,368 |
- |
0.0% |
Other than as set forth above, we have had no material relationship with the selling stockholder during the past three years.
10
We are registering the shares of common stock on behalf of the
selling stockholder. The shares of common stock may be sold in one or more
transactions at fixed prices, at prevailing market prices at the time of sale,
at prices related to the prevailing market prices, at varying prices determined
at the time of sale, or at negotiated prices. These sales may be effected at
various times in one or more of the following transactions on any national
securities exchange or U.S. inter-dealer system of a registered national
securities association on which our common stock may be listed or quoted at the
time of sale, including:
w the Nasdaq National Market;
w in the over-the-counter market;
w in private transactions and transactions otherwise than on these exchanges or
systems or in the over-the-counter market;
w in connection with short sales of the shares;
w by pledge to secure or in payment of debt and other obligations;
w through the writing of options, whether the options are listed on an options
exchange or otherwise;
w in connection with the writing of non-traded and exchange-traded call options,
in hedge transactions and in settlement of other transactions in standardized or
over-the-counter options; or
w through a combination of any of the above transactions.
The selling stockholder and its successors, including its transferees, pledgees
or donees or their successors, may sell the common stock directly to purchasers
or through underwriters, broker-dealers or agents, who may receive compensation
in the form of discounts, concessions or commissions from the selling
stockholder or the purchasers. These discounts, concessions or commissions as to
any particular underwriter, broker-dealer or agent may be in excess of those
customary in the types of transactions involved.
If the selling stockholder uses this prospectus for any sale of the shares of
common stock, it will be subject to the prospectus delivery requirements of the
Securities Act. In addition, any securities covered by this prospectus which
qualify for sale pursuant to Rule 144 of the Securities Act may be sold under
Rule 144 rather than pursuant to this prospectus.
We entered into a registration rights agreement for the benefit of the selling
stockholder to register our common stock under applicable federal and state
securities laws. The registration rights agreement provides for
cross-indemnification of the selling stockholder and us and our respective
directors, officers and controlling persons against specific liabilities in
connection with the offer and sale of the common stock, including liabilities
under the Securities Act. We will pay all costs and expenses associated with the
registration of the resale shares. These costs and expenses include the
Securities and Exchange Commission's filing fees and fees under state securities
or "blue sky" laws, and legal, accounting, printing, and other costs related to
the registration of the shares. The selling stockholder will pay any
underwriting discounts, commissions or concessions, transfer taxes and other
expenses associated with any sale of the shares of common stock by it.
11
Cooley Godward LLP, Palo Alto, California will pass upon the validity of the issuance of the common stock offered by this prospectus.
The financial statements incorporated in this Prospectus by
reference to the Annual Report on Form 10-K of Chordiant Software, Inc. for the
year ended December 31, 2002, have been so incorporated in reliance on the
report of PricewaterhouseCoopers LLP, independent accountants, given on the
authority of said firm as experts in auditing and accounting.
12
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the SEC a resale registration statement on
Form S-3 to register the common stock offered by this prospectus. However, this
prospectus does not contain all of the information contained in the registration
statement and the exhibits and schedules to the registration statement. We
strongly encourage you to carefully read the registration statement and the
exhibits and schedules to the registration statement.
We are a reporting company and file annual, quarterly and current reports, proxy
statements and other information with the SEC. You may read and copy these
reports, proxy statements and other information at the SEC's public reference
room at 450 Fifth Street, N.W., Washington, DC 20549. Please call the SEC at
1-800-SEC-0330 for more information about the operation of the public reference
rooms. Our SEC filings are also available at the SEC's Web site at "http://www.sec.gov."
The SEC allows us to "incorporate by reference" other information that we file
or have filed with the SEC, which means that we can disclose important
information to you by referring you to those documents. The information
incorporated by reference is an important part of this prospectus. Information
that we later file with the SEC will automatically update and replace the
information in this prospectus. We incorporate by reference the documents listed
below:
w our Annual Report on Form 10-K for the year ended December 31, 2002 (File No.
0-29357), filed with the SEC on March 28, 2003;
w our Quarterly Report on Form 10-Q for the quarter ended March 31, 2004 (File
No. 0-29357), filed with the SEC on May 15, 2003;
w our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003 (File
No. 0-29357), filed with the SEC on August 14, 2003;
w our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003
(File No. 0-29357), filed with the SEC on November 3, 2003;
w our Current Reports on Form 8-K (File No. 0-29357), filed with the SEC on
March 11, 2003, September 10, 2003, January 20, 2004 and January 26, 2004;
w the description of our common stock contained in our Registration Statement on
Form 8-A (File No. 0-29357), filed with the SEC on February 7, 2000; and
w any future filings which we make with the SEC under Sections 13(a), 13(c), 14
or 15(d) of the Securities and Exchange Act of 1934, until the selling
stockholder has sold all of the securities that we have registered with the
registration statement.
We will provide to you at no cost a copy of any and all of the information
incorporated by reference into the registration statement of which this
prospectus is a part. You may make a request for copies of this information in
writing or by telephone. Requests should be directed to:
Chordiant Software, Inc.
Attention: Investor Relations
20400 Stevens Creek Blvd., Suite #400
Cupertino, CA 95014
(408) 517-6100
13
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution
Securities and Exchange Commission registration fee |
$3,272.06 |
Legal fees and expenses |
$60,000.00 |
Accountants' fees |
$30,000.00 |
Total |
$93,272.06 |
The foregoing items, except for the Securities and Exchange
Commission registration fee, are estimated. All of the above expenses will be
paid by the registrant.
Item 15. Indemnification of Directors and Officers
Under Section 145 of the Delaware General Corporation Law, the Registrant has
broad powers to indemnify its Directors and officers against liabilities they
may incur in such capacities, including liabilities under the Securities Act.
The Registrant's Amended and Restated Certificate of Incorporation and By-laws
include provisions to (i) eliminate the personal liability of its directors for
monetary damages resulting from breaches of their fiduciary duty to the extent
permitted by Section 102(b)(7) of the General Corporation Law of Delaware (the
"Delaware Law") and (ii) require the Registrant to indemnify its directors and
officers to the fullest extent permitted by Section 145 of the Delaware Law,
including circumstances in which indemnification is otherwise discretionary.
Pursuant to Section 145 of the Delaware Law, a corporation generally has the
power to indemnify its present and former directors, officers, employees and
agents against expenses incurred by them in connection with any suit to which
they are, or are threatened to be made, a party by reason of their serving in
such positions so long as they acted in good faith and in a manner they
reasonably believed to be in, or not opposed to, the best interests of the
corporation and with respect to any criminal action they had no reasonable cause
to believe their conduct was unlawful. The Registrant believes that these
provisions are necessary to attract and retain qualified persons as directors
and officers. These provisions do not eliminate the directors' duty of care,
and, in appropriate circumstances, equitable remedies such as injunctive or
other forms of non-monetary relief will remain available under Delaware Law. In
addition, each director will continue to be subject to liability for breach of
the director's duty of loyalty to the Registrant, for acts or omissions not in
good faith or involving intentional misconduct, for knowing violations of law,
for acts or omissions that the director believes to be contrary to the best
interests of the Registrant or its stockholders, for any transaction from which
the director derived an improper personal benefit, for acts or omissions
involving a reckless disregard for the director's duty to the Registrant or its
stockholders when the director was aware or should have been aware of a risk of
serious injury to the Registrant or its stockholders, for acts or omissions that
constitute an unexcused pattern of inattention that amounts to an abdication of
the director's duty to the Registrant or its stockholders, for improper
transactions between the director and the Registrant and for improper
distributions to stockholders and loans to directors and officers. The provision
also does not affect a director's responsibilities under any other law, such as
the federal securities law or state or federal environmental laws.
The Registrant has entered into indemnity agreements with each of its directors
and executive officers that require the Registrant to indemnify such persons
against expenses, judgments, fines, settlements and other amounts incurred
(including expenses of a derivative action) in connection with any proceeding,
whether actual or threatened, to which any such person may be made a party by
reason of the fact that such person is or was a director or an executive officer
of the Registrant or any of its affiliated enterprises, provided that such
person acted in good faith and in a manner such person reasonably believed to be
in or not opposed to the best interests of the Registrant and, with respect to
any criminal proceeding, had no reasonable cause to believe his conduct was
unlawful. The indemnification agreements also set forth certain procedures that
will apply in the event of a claim for indemnification thereunder.
The Registrant has an insurance policy covering the officers and Directors of
the Registrant with respect to certain liabilities, including liabilities
arising under the Securities Act or otherwise.
II-1
In connection with this offering, the selling stockholder has
agreed to indemnify the Registrant, its directors and officers and each such
person who controls the Registrant, against any and all liability arising from
inaccurate information provided to the Registrant by the selling stockholder and
contained herein up to a maximum of the net proceeds received by the selling
stockholder from the sale of its shares hereunder.
Item 16. Exhibits
Exhibit No. |
Description of Document |
4.1 |
Specimen Common Stock Certificate (filed as Exhibit 4.2 with Amendment No. 2 to Chordiant's Registration Statement on Form S-1 (No. 333-92187) filed on February 7, 2000 and incorporated herein by reference). |
4.5 |
Registration Rights Agreement by and between Chordiant and Acqua Wellington Opportunity I Limited, dated January 22, 2004 (filed as Exhibit 4.5 to Form 8-K filed with the SEC on January 26, 2004 and incorporated herein by reference). |
5.1 |
Opinion of Cooley Godward LLP. |
23.1 |
Consent of PricewaterhouseCoopers LLP. |
23.2 |
Consent of Cooley Godward LLP. Reference is made to Exhibit 5.1. |
24.1 |
Power of Attorney. See signature page. |
Item 17. Undertakings
The undersigned registrant hereby undertakes:
1. To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(a) To include any prospectus required by Section 10(a)(3) of the Securities
Act;
(b) To reflect in the prospectus any facts or events arising after the effective
date of the registration statement (or the most recent post- effective amendment
thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20 percent change in the maximum aggregate
offering price set forth in the "Calculation of Registration Fee" table in the
effective registration statement; and
(c) To include any material information with respect to the plan of distribution
not previously disclosed in the registration statement or any material change to
such information in the registration statement;
provided, however, that paragraphs 1.(a) and 1.(b) do not apply if the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the
Commission by the registrant pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the registration
statement.
2. That, for the purpose of determining any liability under the Securities Act,
each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered herein, and the offering of such
securities at that time shall be deemed to be the bona fide offering thereof.
II-2
3. To remove from
registration by means of a post-effective amendment any of the securities being
registered which remain unsold at the termination of the offering.
The undersigned registrant hereby undertakes that, for purposes of determining
any liability under the Securities Act, each filing of the registrant's annual
report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934
(and, where applicable, each filing of an employee benefit plan's annual report
pursuant to section 15(d) of the Securities Exchange Act of 1934) that is
incorporated by reference in the registration statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act may
be permitted to directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the registrant has been
advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
II-3
SIGNATURES
Pursuant to the
requirements of the Securities Act of 1933, the Registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing
on Form S-3 and has duly caused this Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized in the City of Cupertino,
State of California, this 10th day of February, 2004.
Chordiant Software, Inc. |
(Registrant) | |
By: /s/Stephen Kelly |
| |
Stephen Kelly | |
Chief Executive Officer | |
(Principal Executive Officer) |
POWER OF ATTORNEY
Signature |
Title |
Date |
/s/ Stephen Kelly |
Chief Executive Officer and Director (Principal Executive Officer) |
February 10, 2004 |
/s/ Michael J. Shannahan |
Chief Financial Officer, Chief Accounting
Officer (Principal Financial and Accounting Officer) |
February 10, 2004 |
/s/ Samuel T. Spadafora |
Chairman of the Board and Director |
February 10, 2004 |
/s/ David R. Springett |
Director |
February 10, 2004 |
/s/ George Reyes |
Director |
February 10, 2004 |
/s/ Andrew Eckert |
Director |
February 10, 2004 |
/s/ William Raduchel |
Director |
February 10, 2004 |
/s/ Steven R. Springsteel |
Director |
February 10, 2004 |
II-4
INDEX TO EXHIBITS
Exhibit No. |
Description of Document |
4.1 |
Specimen Common Stock Certificate (filed as Exhibit 4.2 with Amendment No. 2 to Chordiant's Registration Statement on Form S-1 (No. 333-92187) filed on February 7, 2000 and incorporated herein by reference). |
4.5 |
Registration Rights Agreement by and between Chordiant and Acqua Wellington Opportunity I Limited, dated January 22, 2004 (filed as Exhibit 4.5 to Form 8-K filed with the SEC on January 26, 2004 and incorporated herein by reference). |
5.1 |
Opinion of Cooley Godward LLP. |
23.1 |
Consent of PricewaterhouseCoopers LLP. |
23.2 |
Consent of Cooley Godward LLP. Reference is made to Exhibit 5.1. |
24.1 |
Power of Attorney. See signature page. |